Erratum to: Metastatic spine tumor surgery: does perioperative blood transfusion influence postoperative complications?: ABT AND POSTOPERATIVE COMPLICATIONS (Transfusion, (2017), 57, 11, (2790-2798), 10.1111/trf.14311);Metastatic spine tumor surgery: does perioperative blood transfusion influence postoperative complications?

Transfusion

Volumn 57, Issue 11, 2017, Pages 2790-2798

  Zaw, Aye Sandar ^a   Kantharajanna, Shashidhar B ^a   Maharajan, Karthikeyan ^a   Tan, Barry ^a   Saparamadu, Amarasinghe A ^b   Kumar, Naresh ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b ALEXANDRA HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; RETROSPECTIVE STUDY; SPINE METASTASIS; SPINE SURGERY; AGED; BLOOD TRANSFUSION REACTION; COMPLICATION; INFECTION; METASTASIS; PATHOLOGY; SPINE TUMOR; STATISTICAL MODEL; TREATMENT OUTCOME; UTILIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; FEMALE; HUMANS; INFECTION; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SPINAL NEOPLASMS; TRANSFUSION REACTION; TREATMENT OUTCOME;

EID: 85032980318     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.15326     Document Type: Erratum

References (51)

1. Fehlings MG, Nater A, Tetreault L, et al. Survival and clinical outcomes in surgically treated patients with metastatic epidural spinal cord compression: results of the Prospective Multicenter AOSpine Study. J Clin Oncol 2016;34:268-76.
2. Kooby DA, Stockman J, Ben-Porat L, et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003;237:860-9. discussion 9-70.
3. Lee J, Radulescue V, Porhomayon J, et al. The role of perioperative transfusion on long-term survival of veterans undergoing surgery. Ann Surg 2015;261:104-10.
4. Blajchman MA. Transfusion immunomodulation or TRIM: what does it mean clinically? Hematology 2005;10Suppl1:208-14.
5. Buddeberg F, Schimmer BB, Spahn DR. Transfusion-transmissible infections and transfusion-related immunomodulation. Best Pract Res Clin Anaesthesiol 2008;22:503-17.
6. Lannan KL, Sahler J, Spinelli SL, et al. Transfusion immunomodulation—the case for leukoreduced and (perhaps) washed transfusions. Blood Cells Mol Dis 2013;50:61-8.
7. Rohde JM, Dimcheff DE, Blumberg N, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 2014;311:1317-26.
8. Triulzi DJ, Vanek K, Ryan DH, et al. A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion 1992;32:517-24.
9. Kim JM, Losina E, Bono CM, et al. Clinical outcome of metastatic spinal cord compression treated with surgical excision ± radiation versus radiation therapy alone: a systematic review of literature. Spine 2012;37:78-84.
10. Carson JL, Altman DG, Duff A, et al. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999;39:694-700.
11. Murphy P, Heal JM, Blumberg N. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion 1991;31:212-7.
12. Schwarzkopf R, Chung C, Park JJ, et al. Effects of perioperative blood product use on surgical site infection following thoracic and lumbar spinal surgery. Spine 2010;35:340-6.
13. Woods BI, Rosario BL, Chen A, et al. The association between perioperative allogeneic transfusion volume and postoperative infection in patients following lumbar spine surgery. J Bone Joint Surg Am 2013;95:2105-10.
14. Janssen SJ, Braun Y, Wood KB, et al. Allogeneic blood transfusions and postoperative infections after lumbar spine surgery. Spine J 2015;15:901-9.
15. Kato S, Chikuda H, Ohya J, et al. Risk of infectious complications associated with blood transfusion in elective spinal surgery—a propensity score matched analysis. Spine J 2016;16:55-60.
16. Seicean A, Alan N, Seicean S, et al. The effect of blood transfusion on short-term, perioperative outcomes in elective spine surgery. J Clin Neurosci 2014;21:1579-85.
17. Paulino Pereira NR, Langerhuizen DW, Janssen SJ, et al. Are perioperative allogeneic blood transfusions associated with 90-days infection after operative treatment for bone metastases? J Surg Oncol 2016;114:997-1003.
18. Vamvakas EC, Moore SB, Cabanela M. Blood transfusion and septic complications after hip replacement surgery. Transfusion 1995;35:150-6.
19. Clausen C, Lonn L, Morgen SS, et al. Perioperative blood transfusion does not decrease survival after surgical treatment of spinal metastases. Eur Spine J 2014;23:1791-6.
20. Paulino Pereira NR, Beks RB, Janssen SJ, et al. Are allogeneic blood transfusions associated with decreased survival after surgical treatment for spinal metastases? Spine J 2016;16:951-61.
21. Zaw AS, Kantharajanna SB, Maharajan K, et al. Perioperative blood transfusion: does it influence survival and cancer progression in metastatic spine tumor surgery? Transfusion 2016;57:440-50.
22. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
23. Bilsky MH, Laufer I, Fourney DR, et al. Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine 2010;13:324-8.
24. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-13.
25. Kumar N, Zaw AS, Khine HE, et al. Blood loss and transfusion requirements in metastatic spinal tumor surgery: evaluation of influencing factors. Ann Surg Oncol 2016;23:2079-86.
26. Kumar N, Zaw AS, Reyes MR, et al. Versatility of percutaneous pedicular screw fixation in metastatic spine tumor surgery: a prospective analysis. Ann Surg Oncol 2015;22:1604-11.
27. Cole DJ, Ferguson CM. Complications of hepatic resection for colorectal carcinoma metastasis. Am Surg 1992;58:88-91.
28. Kinoshita Y, Udagawa H, Tsutsumi K, et al. Usefulness of autologous blood transfusion for avoiding allogenic transfusion and infectious complications after esophageal cancer resection. Surgery 2000;127:185-92.
29. Mynster T, Christensen IJ, Moesgaard F, et al. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group. Br J Surg 2000;87:1553-62.
30. Gruttadauria S, Saint Georges Chaumet M, Pagano D, et al. Impact of blood transfusion on early outcome of liver resection for colorectal hepatic metastases. J Surg Oncol 2011;103:140-7.
31. Ribeiro HS, Costa WL Jr, Diniz AL, et al. Extended preoperative chemotherapy, extent of liver resection and blood transfusion are predictive factors of liver failure following resection of colorectal liver metastasis. Eur J Surg Oncol 2013;39:380-5.
32. Elsamadicy AA, Adogwa O, Vuong VD, et al. Association of intra-operative blood transfusions on post-operative complications, 30-day readmission rates, and one-year patient reported outcomes. Spine (Phila Pa 1976) 2017;42:610-5.
33. Alfieri S, Carriero C, Caprino P, et al. Avoiding early postoperative complications in liver surgery. A multivariate analysis of 254 patients consecutively observed. Dig Liver Dis 2001;33:341-6.
34. Blumberg N, Heal JM. Effects of transfusion on immune function. Cancer recurrence and infection. Arch Pathol Lab Med 1994;118:371-9.
35. Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513-6.
36. Vamvakas EC. Possible mechanisms of allogeneic blood transfusion-associated postoperative infection. Transfus Med Rev 2002;16:144-60.
37. Browne JA, Cook C, Pietrobon R, et al. Diabetes and early postoperative outcomes following lumbar fusion. Spine 2007;32:2214-9.
38. Fang A, Hu SS, Endres N, et al. Risk factors for infection after spinal surgery. Spine (Phila Pa 1976) 2005;30:1460-5.
39. Demura S, Kawahara N, Murakami H, et al. Surgical site infection in spinal metastasis: risk factors and countermeasures. Spine 2009;34:635-9.
40. Mustoe TA, Porras-Reyes BH. Modulation of wound healing response in chronic irradiated tissues. Clin Plast Surg 1993;20:465-72.
41. Khuri SF, Henderson WG, DePalma RG, et al. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg 2005;242:326-41; discussion 341-3.
42. Gruskay JA, Fu M, Bohl DD, et al. Factors affecting length of stay after elective posterior lumbar spine surgery: a multivariate analysis. Spine J 2015;15:1188-95.
43. Mesfin A, Sciubba D, Dea N, et al. Changing the adverse event profile in metastatic spine surgery: an evidence based approach to target wound complications and instrumentation failure. Spine (Phila Pa 1976) 2016;41Suppl20:S262-70.
44. Sixty-third World Health Assembly: WHA63.12, Availability, safety and quality of blood products [Internet]. Geneva: World Health Organization; 2010 [cited 2016 Mar 13]. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_R12-en.pdf.
45. Spahn DR, Shander A, Hofmann A. The chiasm: transfusion practice versus patient blood management. Best Pract Res Clin Anaesthesiol 2013;27:37-42.
46. Kumar N, Ahmed Q, Lee VK, et al. Can there be a place for intraoperative salvaged blood in spine tumor surgery? Ann Surg Oncol 2014;21:2436-43.
47. Kumar N, Ahmed Q, Lee VK, et al. Are we ready for the use of intraoperative salvaged blood in metastatic spine tumour surgery? Eur Spine J 2015;25:3997-4007.
48. Kumar N, Chen Y, Zaw AS, et al. Use of intraoperative cell-salvage for autologous blood transfusions in metastatic spine tumour surgery: a systematic review. Lancet Oncol 2014;15:e33-41.
49. Kumar N, Lam R, Zaw AS, et al. Flow cytometric evaluation of the safety of intraoperative salvaged blood filtered with leucocyte depletion filter in spine tumour surgery. Ann Surg Oncol 2014;21:4330-5.
50. Kumar N, Zaw AS, Khoo BL, et al. Intraoperative cell salvage in metastatic spine tumour surgery reduces potential for reinfusion of viable cancer cells. Eur Spine J 2016;25:4008-15.
51. Zaw AS, Bangalore Kantharajanna S, Kumar N. Is autologous salvaged blood a viable option for patient blood management in oncologic surgery? Transfus Med Rev 2016;31:56-61.